Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

Maxy: if you're talking scripts, breakeven should be somewhere around 15,000. Some will have different numbers but that number should give Amarin about $160m per year sales revs. Currently we're @ $80m. Others jump in here. Someone posted its all about the FDA. But if Lovaza could be a blockbuster in the Marine population then regardless of the FDA Vascepa should be fine on its own.